Oppenheimer has downgraded Aurinia Pharmaceuticals(NASDAQ:AUPH)from outperform to perform following a report thatthe company may be acquired by Bristol-Myers Squibb(NYSE:BMY). In addition, the firm ...
网页链接Oppenheimer has downgraded Aurinia Pharmaceuticals(NASDAQ:AUPH)from outperform to perform following a report thatthe company may be acquired by Bristol-Myers Squibb(NYSE:BMY). In addition, the firm ...
网页链接
精彩评论